{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T22:40:07Z","timestamp":1720305607461},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,5]]},"DOI":"10.4103\/0366-6999.232791","type":"journal-article","created":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T06:01:19Z","timestamp":1526882479000},"page":"1289-1295","source":"Crossref","is-referenced-by-count":0,"title":["Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood"],"prefix":"10.1097","volume":"131","author":[{"given":"Pei-Wen","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Mei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ning","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Chun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruo-Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40880-017-0257-9","article-title":"Nasopharyngeal carcinoma incidence and mortality in China, 2013 (In Chinese)","volume":"36","author":"Wei","year":"2017","journal-title":"Chin J Cancer"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcancer.2012.01.007","article-title":"Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors","volume":"22","author":"Hildesheim","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.oraloncology.2014.02.006","article-title":"Etiological factors of nasopharyngeal carcinoma","volume":"50","author":"Tsao","year":"2014","journal-title":"Oral Oncol"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00432-012-1313-0","article-title":"Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: Long-term outcome of a multicenter prospective study","volume":"139","author":"Wang","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"e1938","DOI":"10.1371\/journal.pntd.0001938","article-title":"T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs","volume":"7","author":"de Melo","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2567.2010.03383.x","article-title":"Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides","volume":"132","author":"Wang","year":"2011","journal-title":"Immunology"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1200\/JCO.2015.60.7846","article-title":"Nasopharyngeal cancer: Molecular landscape","volume":"33","author":"Bruce","year":"2015","journal-title":"J Clin Oncol"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ajh.22141","article-title":"Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia","volume":"86","author":"Atanackovic","year":"2011","journal-title":"Am J Hematol"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.3760\/cma.j.issn.0366-6999.20130526","article-title":"Demethylating agent decitabine induces autologous cancer testis antigen specific cytotoxic T lymphocytes in vivo","volume":"126","author":"Zhou","year":"2013","journal-title":"Chin Med J"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF01246677","article-title":"Structure, chromosomal localization, and expression of 12 genes of the MAGE family","volume":"40","author":"De Plaen","year":"1994","journal-title":"Immunogenetics"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"408","DOI":"10.5483\/BMBRep.2012.45.7.068","article-title":"Cross-immunizing potential of tumor MAGE-A epitopes recognized by HLA-A*02:01-restricted cytotoxic T lymphocytes","volume":"45","author":"Huang","year":"2012","journal-title":"BMB Rep"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4049\/jimmunol.1001775","article-title":"A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer","volume":"186","author":"Chinnasamy","year":"2011","journal-title":"J Immunol"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.10634","article-title":"The SSX gene family: Characterization of 9 complete genes","volume":"101","author":"G\u00fcre","year":"2002","journal-title":"Int J Cancer"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"150591","DOI":"10.1155\/2010\/150591","article-title":"The SSX family of cancer-testis antigens as target proteins for tumor therapy","volume":"2010","author":"Smith","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.4049\/jimmunol.172.11.7206","article-title":"Identification of an SSX-2 epitope presented by dendritic cells to circulating autologous CD4+T cells","volume":"172","author":"Ayyoub","year":"2004","journal-title":"J Immunol"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4049\/jimmunol.168.4.1717","article-title":"Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma","volume":"168","author":"Ayyoub","year":"2002","journal-title":"J Immunol"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2407-10-163","article-title":"Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines","volume":"10","author":"Zhang","year":"2010","journal-title":"BMC Cancer"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1158\/1535-7163.MCT-14-0796","article-title":"A comprehensive expression analysis of cancer testis antigens in head and neck squamous cell carcinoma revels MAGEA3\/6 as a marker for recurrence","volume":"14","author":"Zamun\u00e9r","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/1078-0432.CCR-16-0557","article-title":"A threshold of systemic MAGE-A gene expression predicting survival in resected non-small cell lung cancer","volume":"23","author":"Mecklenburg","year":"2017","journal-title":"Clin Cancer Res"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/pros.20665","article-title":"Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor","volume":"67","author":"Dubovsky","year":"2007","journal-title":"Prostate"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00262-010-0916-z","article-title":"MAGE-A3 and MAGE-A4 specific CD4(+) T cells in head and neck cancer patients: Detection of naturally acquired responses and identification of new epitopes","volume":"60","author":"Cesson","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/JTO.0000000000000653","article-title":"Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with or without adjuvant chemotherapy in patients with resected stage IB to III MAGE-A3-positive non-small-cell lung cancer","volume":"10","author":"Pujol","year":"2015","journal-title":"J Thorac Oncol"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","article-title":"Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Vansteenkiste","year":"2016","journal-title":"Lancet Oncol"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1093\/hmg\/ddv270","article-title":"Antigen-specific T cell therapies for cancer","volume":"24","author":"Manzo","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12865-015-0113-0","article-title":"Immune cell subsets and their gene expression profiles from human PBMC isolated by vacutainer cell preparation tube (CPT\u2122) and standard density gradient","volume":"16","author":"Corkum","year":"2015","journal-title":"BMC Immunol"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/cells1020111","article-title":"ELISPOT assay for monitoring cytotoxic T lymphocytes (CTL) activity in cancer vaccine clinical trials","volume":"1","author":"Malyguine","year":"2012","journal-title":"Cells"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.semcancer.2012.01.012","article-title":"Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma","volume":"22","author":"Bei","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1021\/acs.biochem.5b01077","article-title":"Clusters of Structurally Similar MHC I HLA-A2 Molecules, Found with a New Method, Suggest Mechanisms of T-Cell Receptor Avidity","volume":"55","author":"Rashin","year":"2016","journal-title":"Biochemistry"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/iji.12254","article-title":"HLA-A, -B and -DRB1 allele and haplotype frequencies of 8333 Chinese Han from the Zhejiang province, China","volume":"43","author":"He","year":"2016","journal-title":"Int J Immunogenet"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3389\/fonc.2013.00299","article-title":"Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers","volume":"3","author":"Su","year":"2013","journal-title":"Front Oncol"},{"key":"R32-5-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/tan.12576","article-title":"Sequence-based typing of HLA-A gene in 930 patients with nasopharyngeal carcinoma in Hunan province, Southern China","volume":"86","author":"Tian","year":"2015","journal-title":"Tissue Antigens"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.humimm.2013.12.015","article-title":"Association analysis between HLA-A, -B, -C, -DRB1, and -DQB1 with nasopharyngeal carcinoma among a Han population in Northwestern China","volume":"75","author":"Wang","year":"2014","journal-title":"Hum Immunol"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s11596-016-1647-y","article-title":"HLA-A*02-B*46 haplotype: An adverse prognostic factor in Han patients with nasopharyngeal carcinoma","volume":"36","author":"Wang","year":"2016","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"434072","DOI":"10.1155\/2014\/434072","article-title":"Evaluation and integration of genetic signature for prediction risk of nasopharyngeal carcinoma in Southern China","volume":"2014","author":"Guo","year":"2014","journal-title":"Biomed Res Int"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.4161\/21645515.2014.973317","article-title":"Antigen-specific vaccines for cancer treatment","volume":"10","author":"Tagliamonte","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.athoracsur.2015.05.089","article-title":"Pulmonary metastases exhibit epigenetic clonality: Implications for precision cancer therapy","volume":"100","author":"Reardon","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/ol.2013.1351","article-title":"The expression and clinical significance of melanoma-associated antigen-A1, -A3 and -A11 in glioma","volume":"6","author":"Guo","year":"2013","journal-title":"Oncol Lett"},{"key":"R39-5-20210129","doi-asserted-by":"crossref","first-page":"e000203","DOI":"10.1136\/esmoopen-2017-000203","article-title":"Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: An open phase I\/II study with a first assessment of a predictive gene signature","volume":"2","author":"Grob","year":"2017","journal-title":"ESMO Open"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00262-014-1529-8","article-title":"P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma","volume":"63","author":"Terashima","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"R41-5-20210129","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2009.04.045","article-title":"Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma","volume":"137","author":"Gehring","year":"2009","journal-title":"Gastroenterology"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1200\/JCO.2012.43.7111","article-title":"Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma","volume":"31","author":"Kruit","year":"2013","journal-title":"J Clin Oncol"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4049\/jimmunol.169.1.575","article-title":"Generation of CTL recognizing an HLA-A*0201-restricted epitope shared by MAGE-A1, -A2, -A3, -A4, -A6, -A10, and -A12 tumor antigens: Implication in a broad-spectrum tumor immunotherapy","volume":"169","author":"Graff-Dubois","year":"2002","journal-title":"J Immunol"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/CJI.0b013e31822b5b1d","article-title":"Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells","volume":"34","author":"Smith","year":"2011","journal-title":"J Immunother"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.232791","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T21:57:26Z","timestamp":1720303046000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201806050-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.232791","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,5]]}}}